Commentary
Increased vulnerability of photoreceptors to aberrant splicing highlight the utility of AON-based therapy for CEP290-LCA
Stem Cell Investigation
2016;
3:
96
(27 December 2016)
Short Report
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trial
Stem Cell Investigation
2016;
3:
95
(23 December 2016)
Perspective
Outside the brain: an inside view on transgenic animal and stem cell-based models to examine neuronal serotonin-dependent regulation of HPA axis-controlled events during development and adult stages
Stem Cell Investigation
2016;
3:
94
(19 December 2016)
Commentary
Combining retinoic acid and oral arsenic may be potentially the first-line therapy for non-high-risk acute promyelocytic leukemia
Stem Cell Investigation
2016;
3:
93
(19 December 2016)
Commentary
Novel methods for the treatment of liver fibrosis using in vivo direct reprogramming technology
Stem Cell Investigation
2016;
3:
92
(09 December 2016)
Editorial
Cell sources for regenerative medicine of the liver and endoderm organs: strategies and perspectives
Stem Cell Investigation
2016;
3:
91
(09 December 2016)
Review Article
Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients
Stem Cell Investigation
2016;
3:
90
(09 December 2016)
Editorial
Comment on: Expandable cardiovascular progenitor cells reprogrammed from fibroblasts
Stem Cell Investigation
2016;
3:
89
(09 December 2016)
Commentary
Blocking TGF-β and BMP SMAD-dependent cell differentiation is a master key to expand all kinds of epithelial stem cells
Stem Cell Investigation
2016;
3:
88
(08 December 2016)
Case Report
Bone marrow derived stem cell therapy for type 2 diabetes mellitus
Stem Cell Investigation
2016;
3:
87
(06 December 2016)
Perspective
The silver lining of induced pluripotent stem cell variation
Stem Cell Investigation
2016;
3:
86
(06 December 2016)